Overall nearly one in five adults (18%) say at some point they have taken a GLP-1 drug, a class of medications used for weight loss and to treat diabetes, heart disease, and other chronic conditions
One-Year Mortality after Contemporary Laparoscopic Bariatric Surgery: An Analysis of the Bariatric Outcomes Longitudinal Database
Prof.Ramani Arsecularatne Graduated from Christine Valmy Institute of New York and Kimari International in Singapore, she is the first Sri Lankan to obtain a degree in beauty & hairdressing
This hormone slows gastric emptying, reduces cravings, and improves insulin response
Tea Extracts However, both Thompson and Auda caution against using most over-the-counter products that claim to drive weight loss
The FDA resolved the semaglutide and tirzepatide shortages in 2025, ending the broad shortage-based pathway that powered large-scale compounding, and in April 2026 proposed excluding these drugs from the 503B bulks list, with a comment period through June 29, 2026